Tumor-Specific Idiotype Vaccines in the Treatment of Patients With B-Cell Lymphoma — Long-Term Results of a Clinical Trial
Open Access
- 1 May 1997
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 89 (9) , 3129-3135
- https://doi.org/10.1182/blood.v89.9.3129
Abstract
The surface Ig on each B-cell lymphoma has unique portions (idiotypes), which can be recognized by the immune system. In this study, we immunized patiKeywords
This publication has 22 references indexed in Scilit:
- Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cellsNature Medicine, 1996
- Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphomaNature, 1993
- Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their TumorsNew England Journal of Medicine, 1992
- Clonal evolution of a follicular lymphoma: evidence for antigen selection.Proceedings of the National Academy of Sciences, 1992
- Somatic Mutation in Human B‐Cell TumorsImmunological Reviews, 1987
- Mouse × human heterohybridomas as fusion partners with human B cell tumorsJournal of Immunological Methods, 1986
- Emergence of Idiotype Variants during Treatment of B-Cell Lymphoma with Anti-Idiotype AntibodiesNew England Journal of Medicine, 1985
- A clinical trial of anti-idiotype therapy for B cell malignancyBlood, 1985
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- Immunoregulation of Murine Myeloma Cell Growth and Differentiation; A Monoclonal Model of B Cell Differentiation1Immunological Reviews, 1979